References
I. H. Fox and W. N. Kelley,The role of adenosine and 2′-deoxyadenosine in mammalian cells. Ann. Rev. Biochem.47, 655–686 (1978).
N. M. Kredich and M. S. Hershfield,Perturbations in S-Adenosylhomocyteine and S-Adenosylmethionine metabolism: Effects on transmethylation. Adv. Enzyme Reg.18, 181–191 (1980).
A. N. Drury and A. Szent-Györgyi,Physiological activity of adenine compounds with especial reference to their action upon mammalian heart. J. Physiol. (London)68, 213–237 (1929).
R. M. Berne,Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am. J. Physiol.204, 317–322 (1963).
M. J. Cushley, A. E. Tattersfield and S. T. Holgate,Adenosine-induced bronchoconstriction in asthma. Amer. Rev. Respir. Dis.129, 380–384 (1984).
J. R. S. Arch and E. A. Newsholme,The control of the metabolism and the hormonal role of adenosine. Essays Biochem.14, 82–123 (1978).
J. W. Daly, R. F. Bruns and S. H. Snyder,Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthines. Life Sciences28, 2083–2097 (1981).
Regulatory function of adenosine. Proceedings of the international symposium on adenosine. Charlottesville, VA, June 7–11, 1982 (Eds. R. M. Berne, T. W. Rall and R. Rubio) Martinus Nijhoff Publishers, Boston/The Hague/Dordrecht/Lancaster (1983).
E. R. Giblett, J. E. Anderson, F. Cohen, B. Pollara and H. J. Meuwissen,Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancetii, 1067–1069 (1972).
B. S. Mitchell and W. N. Kelley,Purinogenic immunodeficiency diseases: Clinical features and molecular mechanisms. Annals Int. Med.92, 826–831 (1980).
L. F. Thompson and J. E. Seegmiller,Adenosine deaminase deficiency and severe combined immunodeficiency disease. Adv. Enzymol.51, 166–210 (1980).
D. W. Martin, Jr. and E. W. Gelfand,Biochemistry of diseases of immunodevelopment. Ann. Rev. Biochem.50, 845–877 (1981).
E. W. Gelfand and A. Cohen,Disorders of purine metabolism and immunodeficiency. InAdv. host defense mechanisms Vol. 2 (Eds. J. I. Gallin and A. S. Fauci) p. 43, Raven Press, New York 1983.
D. A. Carson, E. Lakow, D. B. Wasson and N. Kamatani,Lymphocyte dysfunction caused by deficiencies in purine metabolism. Immunol. Today2, 234–238 (1981).
R. Hirschhorn, J. Grossman and G. Weissmann,Effect of cyclic 3′, 5′-adenosine monophosphate and theophylline on lymphocyte transformation. Proc. Soc. Exptl. Biol. Med.133, 1361–1365 (1970).
G. Wolberg, T. P. Zimmerman, K. Hiemstra, M. Winston and L. C. Chu,Adenosine inhibition of lymphocyte-mediated cytolysis: Possible role of cyclic adenosine monophosphate. Science187, 957–959 (1975).
D. A. Carson and J. E. Seegmiller,Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J. Clin. Invest.57, 274–282 (1976).
F. F. Snyder, J. Mendelsohn and J. E. Seegmiller,Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. J. Clin. Invest.58, 654–666 (1976).
D. A. Carson, D. B. Wasson, E. Lakow and N. Kamatani,Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase. Proc. Natl. Acad. Sci. USA79, 3848–3852 (1982).
R. F. Kefford and R. M. Fox,Purine deoxynucleoside toxicity in nondividing human lymphoid cells. Cancer Res.42, 324–330 (1982).
E. C. Moore and R. B. Hurlbert,Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors. J. Biol. Chem.241, 4802–4809 (1966).
M. F. E. Siaw, B. S. Mitchell, C. A. Koller, M. S. Coleman and J. J. Hutton,ATP depletion as a consequence of adenosine demainase inhibition in man. Proc. natl. Acad. Sci. USA77, 6157–6161 (1980).
L. Brox, A. Ng, E. Pollock and A. Belch,DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin. Cancer Res.44, 934–937 (1984).
H. E. Gruber, A. H. Cohen, S. G. Firestein, D. Redelman and H. G. Bluestein,Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes. InPurine and pyrimidine metabolism in man. Vol. V, Part A (Eds. W. L. Nyhan, L. F. Thompson and R. W. E. Watts) p. 503, Plenum Press, New York and London 1986.
A. Goday, H. A. Simmonds, L. D. Fairbanks and G. S. Morris,B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency. InPurine and pyrimidine metabolism in man. Vol V, Part A (Eds. W. L. Nyhan, L. F. Thompson and R. W. E. Watts) p. 515, Plenum Press, New York and London 1986.
G. Marone, M. Plaut and L. M. Lichtenstein,Characterization of a specific adenosine receptor on human lymphocytes. J. Immunol.121, 2153–2159 (1978).
A. L. Schwartz, R. C. Stern and S. H. Polmar,Demonstration of an adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency. Clin. Immunol. Immunopathol.9, 499–505 (1978).
J. C. Bonnafous, J. Dornand, J. Favero and J. C. Mani,Lymphocyte membrane adenosine receptors coupled to adenylate cyclase. Properties and occurrence in various lymphocyte subclasses. J. Receptor Research2, 347–366 (1981/2).
C. S. Henney, H. R. Bourne and L. M. Lichtenstein,The role of cyclic 3′, 5′-adenosine monophosphate in the specific cytolytic activity of lymphocytes. J. Immunol.108, 1526–1534 (1972).
T. B. Strom, A. Deisseroth, J. Morganroth, C. B. Carpenter and J. P. Merrill,Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc. Natl. Acad. Sci. USA69, 2995–2999 (1972).
L. M. Lichtenstein, C. S. Henney, H. R. Bourne and W. B. Greenough, III,Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. J. Clin. Invest.52, 691–697 (1973).
F. V. Chisari and T. S. Edgington,Human T lymphocyte ‘E’ rosette formation. 1. A process modulated by intracellular cAMP. J. Exp. Med.140, 1122–1126 (1974).
H. Bessler, M. Djaldetti, B. Kupfer and C. Moroz,Two T lymphocyte subpopulations isolated from human peripheral blood following “in vitro” treatment with adenosine. Biomedicine32, 66–71 (1980).
S. Limatibul, A. Shore, H. M. Dosch and E. W. Gelfand,Theophylline modulation of E-rosette formation: An indicator of T-cell maturation. Clin. Exptl. Immunol.33, 503–513 (1978).
C. Moroz and R. H. Stevens,Suppression of immunoglobulin production in normal human B lymphocytes by two T-cell subsets distinguished following in vitro treatment with adenosine. Clin. Immunol. Immunopathol.15, 44–51 (1980).
R. E. Birch and S. H. Polmar,Induction of Fc γ receptors on a subpopulation of human T lymphocytes by adenosine and impromidine, an H 2-histamine agonist. Cell. Immunol.57, 455–467 (1981).
R. E. Birch, A. K. Rosenthal and S. H. Polmar,Pharmacological modification of immunoregulatory T lymphocytes. II. Modulation of T lymphocyte cell surface characteristics. Clin. Exptl. Immunol.48, 231–238 (1982).
R. E. Birch and S. H. Polmar,Adenosine induced immunosuppression: The role of the adenosine receptor-adenylate cyclase interaction in the alteration of T-lymphocyte surface phenotype and immunoregulatory function. Int. J. Immunopharm.8, 329–337 (1986).
C. Londos and J. Wolff,Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. USA74, 5482–5486 (1977).
C. Londos, D. M. F. Cooper, W. Schlegel and M. Rodbell,Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: Basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc. Natl. Acad. Sci. USA75, 5362–5366 (1978).
C. Londos, D. M. F. Cooper and J. Wolff,Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA77, 2551–2554 (1980).
F. W. Smellie, J. W. Daly, T. V. Dunwiddie and B. J. Hoffer,The dextro and levorotatory isomers of n-phenylisopropyladenosine: Stereospecific effects on cyclic AMP-formation and evoked synaptic responses in brain slices. Life Sci.25, 1739–1748 (1979).
U. Schwabe and T. Trost,Characterization of adenosine receptors in rat brain by (−)[3 H]N 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol.313, 179–187 (1980).
M. Williams and E. A. Risley,Biochemical characterization of putative central purinergic receptors by using 2-chloro [3 H]adenosine, a stable analog of adenosine. Proc. natl. Acad. Sci. USA77, 6892–6896 (1980).
R. F. Bruns, J. W. Daly and S. H. Snyder,Adenosine receptors in brain membranes: Binding of N 6-cyclohexyl-[3 H]adenosine and 1,3-diethyl-8-[3 H]phenylxanthine. Proc. Natl. Acad. Sci. USA77, 5547–5551 (1980).
K. M. M. Murphy and S. H. Snyder,Adenosine receptors in rat testes: Labeling with 3 H-cyclohexyladenosine. Life Sci.28, 917–920 (1981).
T. Trost and U. Schwabe,Adenosine receptors in fat cells. identification by (−)-N 6-[3 H]phenylisopropyladenosine binding. Mol. Pharmacol.19, 228–235 (1981).
I. H. Fox and L. Kurpis,Binding characteristics of an adenosine receptor in human placenta. J. Biol. Chem.258, 6952–6955 (1983).
D. L. Marquardt, C. W. Parker and T. J. Sullivan,Potentiation of mast cell mediator release by adenosine. J. Immunol.120 871–878 (1978).
S. P. Peters, E. S. Schulman, R. P. Schleimer, D. W. MacGlashan, Jr., H. H. Newball and L. M. Lichtenstein,Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Amer. Rev. Resp. Dis.126, 1034–1039 (1982).
G. Marone, M. Triggiani, A. Kagey-Sobotka, L. M. Lichtenstein and M. Condorelli,Adenosine receptors on human basophils and lung mast cells. InPurine and pyrimidine metabolism in man. Vol V, Part B (Eds. W. L. Nyhan, L. F. Thompson and R. W. E. Watts) p. 35, Plenum Press, New York and London 1986.
M. C. Pike, N. M. Kredich and R. Snyderman,Requirement of S-adenosyl-l-methionine-mediated methylation for human monocyte chemotaxis. Proc. Natl. Acad. Sci. USA75, 3928–3932 (1978).
G. Marone, L. L. Thomas and L. M. Lichtenstein,The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J. Immunol.125, 2277–2283 (1980).
B. N. Cronstein, S. B. Kramer, G. Weissmann and R. Hirschhorn,A new physiological function for adenosine: regulation of superoxide anion production. Trans. Assoc. Amer. Physicians96, 384–391 (1983).
B. N. Cronstein, S. B. Kramer, G. Weissmann and R. Hirschhorn,Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exptl. Med.158, 1160–1177 (1983).
B. N. Cronstein, S. B. Kramer, G. Weissmann and R. Hirschhorn,Adenosine deaminase is not required for the generation of superoxide anion. Clin. Immunol. Immunopathol.30, 495–499 (1984).
B. N. Cronstein, E. D. Rosenstein, S. B. Kramer, G. Weissmann and R. Hirschhorn,Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A 2 receptor on human neutrophils. J. Immunol.135, 1366–1371 (1985).
M. A. Iannone, R. Reynolds-Vaughn, G. Wolberg and T. P. Zimmerman,Human neutrophils possess adenosine A 2 receptors. Fed. Proc.44, 580A (1985).
T. P. Zimmerman, C. J. Schmitges, G. Wolberg, R. D. Deeprose, G. S. Duncan, P. Cuatrecasas and G. B. Elion,Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes. Proc. Natl. Acad. Sci. USA77, 5639–5643 (1980).
T. P. Zimmerman, M. Iannone and G. Wolberg,3-deazaadenosine. S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes. J. Biol. Chem.259, 1122–1126 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilbertsen, R.B. Adenosine and adenosine receptors in immune function. Minireview and meeting report. Agents and Actions 22, 91–98 (1987). https://doi.org/10.1007/BF01968823
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01968823